These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10358958)

  • 1. [99mTc-MIBI uptake in breast abscess: a case report].
    Ohta H
    Kaku Igaku; 1999 Apr; 36(3):237-40. PubMed ID: 10358958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcifications.
    Fondrinier E; Muratet JP; Anglade E; Fauvet R; Berger V; Lorimier G; Jallet P
    Breast; 2004 Aug; 13(4):316-20. PubMed ID: 15325666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard.
    Chen SL; Yin YQ; Chen JX; Sun XG; Xiu Y; Liu WG; Liu M; Zhu WM; Zhang YB
    Anticancer Res; 1997; 17(3B):1695-8. PubMed ID: 9179221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast scintigraphy with technetium 99m sestamibi, as support to radiologic methods in the study of breast lesions].
    Occhiato R; Schillaci O; Broglia L; Danieli R; Narilli P; Pavone P; Scopinaro F; Passariello R
    Radiol Med; 1996 May; 91(5):581-4. PubMed ID: 8693123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99Tcm-MIBI mammoscintigraphy of breast masses: early and delayed imaging.
    Lu G; Shih WJ; Huang HY; Long MQ; Sun Q; Liu YH; Chou C
    Nucl Med Commun; 1995 Mar; 16(3):150-6. PubMed ID: 7770238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
    Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
    Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
    Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
    Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m-MIBI scintimammography; SPECT versus planar imaging.
    Aziz A; Hashmi R; Ogawa Y; Hayashi K
    Cancer Biother Radiopharm; 1999 Dec; 14(6):495-500. PubMed ID: 10850336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of quantification and visual analysis of the uptake of (99m)Tc-MIBI in the diagnosis of mammary lesions].
    Mulero F; Roca V; Nicolás F; Castellón I; Fuentes T; Abad L; Illana J; Nuño de la Rosa JA
    Rev Esp Med Nucl; 2000 Jun; 19(3):192-8. PubMed ID: 11062082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative evaluation of the chemosensitivity of breast cancer by means of double phase 99mTc-MIBI scintimammography.
    Fujii H; Nakamura K; Kubo A; Enomoto K; Ikeda T; Kubota T; Matsuzaki SW; Kitajima M
    Ann Nucl Med; 1998 Dec; 12(6):307-12. PubMed ID: 9972367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors.
    Ohta H; Komibuchi T; Nishio T; Kitai T; Yamamoto S; Ukikusa M; Awane H; Irie K; Shintaku M
    Ann Nucl Med; 1997 Feb; 11(1):37-9. PubMed ID: 9095321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions.
    Gutfilen B; Fonseca LM
    J Exp Clin Cancer Res; 2001 Sep; 20(3):385-91. PubMed ID: 11718219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions.
    Cutrone JA; Yospur LS; Khalkhali I; Tolmos J; Devito A; Diggles L; Vargas MP; Shitabata P; French S
    J Nucl Med; 1998 Mar; 39(3):449-53. PubMed ID: 9529290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
    Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N
    J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of Tc-99m MIBI related to tumour size and type.
    Buscombe JR; Cwikla JB; Thakrar DS; Hilson AJ
    Anticancer Res; 1997; 17(3B):1693-4. PubMed ID: 9179220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy.
    Carril JM; Gómez-Barquín R; Quirce R; Tabuenca O; Uriarte I; Montero A
    Anticancer Res; 1997; 17(3B):1677-81. PubMed ID: 9179217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
    Papantoniou VJ; Souvatzoglou MA; Valotassiou VJ; Louvrou AN; Ambela C; Koutsikos J; Lazaris D; Christodoulidou JK; Sotiropoulou MG; Melissinou MJ; Perperoglou A; Tsiouris S; Zerva CJ
    Breast Cancer Res; 2004; 6(2):R56-62. PubMed ID: 14979918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.